Arena Pharmaceuticals Inc EBIT margin
Was ist das EBIT margin von Arena Pharmaceuticals Inc?
EBIT margin von Arena Pharmaceuticals Inc ist -1,133,840.74%
Was ist die Definition von EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Arena Pharmaceuticals Inc
Was macht Arena Pharmaceuticals Inc?
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas
Unternehmen mit ebit margin ähnlich Arena Pharmaceuticals Inc
- Nimy Resources Ltd hat EBIT margin von -1,962,988.89%
- Akora Resources Ltd hat EBIT margin von -1,900,440.63%
- Deepti Alloy Steel hat EBIT margin von -1,676,280.26%
- Carpinienne de Participations hat EBIT margin von -1,474,500.00%
- Thin Film Electronics ASA hat EBIT margin von -1,362,200.00%
- Allogene Therapeutics Inc hat EBIT margin von -1,342,523.81%
- Arena Pharmaceuticals Inc hat EBIT margin von -1,133,840.74%
- Aurum Resources Ltd hat EBIT margin von -887,391.20%
- Eastern Metals hat EBIT margin von -812,601.10%
- Willow Biosciences hat EBIT margin von -803,860.14%
- Psyched Wellness hat EBIT margin von -703,101.31%
- Cannon Resources Ltd hat EBIT margin von -666,400.00%
- Tamboran Resources Ltd hat EBIT margin von -530,273.27%